PVOTF - Pivot Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue1/31/20191/31/20181/31/20171/31/2016
Total Revenue----
Cost of Revenue87.864---
Gross Profit-87.864---
Operating Expenses
Research Development430.45690.82690.82690.826
Selling General and Administrative5,400.9151,101.3375,829.08610,307.257
Non Recurring----
Others----
Total Operating Expenses6,819.8861,222.9885,829.08610,307.579
Operating Income or Loss-6,819.886-1,222.988-5,829.086-10,307.579
Income from Continuing Operations
Total Other Income/Expenses Net-2,326.4851,180.634-449.1210.514
Earnings Before Interest and Taxes-6,819.886-1,222.988-5,829.086-10,307.579
Interest Expense-902.008-175.72-81.445-81.445
Income Before Tax-9,146.371-42.354-6,278.207-10,307.065
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-9,146.371-42.354-6,278.207-10,307.065
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-9,146.371-42.354-6,278.207-10,307.065
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-9,146.371-42.354-6,278.207-10,307.065